CO4940408A1 - Composicion de aerosol farmaceutico - Google Patents

Composicion de aerosol farmaceutico

Info

Publication number
CO4940408A1
CO4940408A1 CO98033837A CO98033837A CO4940408A1 CO 4940408 A1 CO4940408 A1 CO 4940408A1 CO 98033837 A CO98033837 A CO 98033837A CO 98033837 A CO98033837 A CO 98033837A CO 4940408 A1 CO4940408 A1 CO 4940408A1
Authority
CO
Colombia
Prior art keywords
aerosol composition
pharmaceutical aerosol
inhaler
composition
aerosol
Prior art date
Application number
CO98033837A
Other languages
English (en)
Inventor
Lewis David
Meakin Brian
Paolo Ventura
Brambilla Gaetano
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940408(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of CO4940408A1 publication Critical patent/CO4940408A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Abstract

Una composición para usar en un inhalador en aerosol,CARACTERIZADA PORQUE comprende un material activo, un propelente que contiene un hidrofluoroalcano (HFA), un cosolvente y que comprende además un componente de baja volatilidad para incrementar la mediana del diámetro aerodinámico de la masa (MMAD) de las partículas del aerosol al activar el inhalador.
CO98033837A 1997-06-13 1998-06-12 Composicion de aerosol farmaceutico CO4940408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
CO4940408A1 true CO4940408A1 (es) 2000-07-24

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98033837A CO4940408A1 (es) 1997-06-13 1998-06-12 Composicion de aerosol farmaceutico

Country Status (45)

Country Link
EP (2) EP0920302B2 (es)
JP (1) JP4380802B2 (es)
KR (1) KR100546239B1 (es)
CN (1) CN1138532C (es)
AR (1) AR012977A1 (es)
AT (1) ATE222751T1 (es)
AU (1) AU729966B2 (es)
BG (1) BG63906B1 (es)
BR (1) BR9805993B1 (es)
CA (1) CA2263445C (es)
CO (1) CO4940408A1 (es)
CZ (1) CZ295521B6 (es)
DE (1) DE69807420T3 (es)
DK (1) DK0920302T4 (es)
DZ (1) DZ2516A1 (es)
EA (1) EA001259B1 (es)
EE (1) EE03664B1 (es)
ES (1) ES2182351T5 (es)
GB (1) GB2326334A (es)
GE (1) GEP20012462B (es)
HK (1) HK1022271A1 (es)
HR (1) HRP980317B1 (es)
HU (1) HU228487B1 (es)
ID (1) ID21491A (es)
IL (1) IL128484A (es)
IN (1) IN189317B (es)
IS (1) IS2435B (es)
IT (1) IT1293803B1 (es)
MA (1) MA26507A1 (es)
ME (2) MEP44008A (es)
MY (1) MY119074A (es)
NO (1) NO327775B1 (es)
NZ (1) NZ334149A (es)
PL (1) PL193721B1 (es)
PT (1) PT920302E (es)
RS (1) RS51274B (es)
SA (1) SA98190821B1 (es)
SI (1) SI0920302T2 (es)
SK (1) SK284430B6 (es)
TN (1) TNSN98087A1 (es)
TR (1) TR199900288T1 (es)
TW (1) TW555570B (es)
UA (1) UA70289C2 (es)
WO (1) WO1998056349A1 (es)
ZA (1) ZA985136B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AU7026800A (en) 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CA2411047C (en) 2000-05-22 2009-08-04 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
LT3494995T (lt) 2002-03-01 2020-04-10 Chiesi Farmaceutici S.P.A. Ypatingai smulki formoterolio kompozicija
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
KR101113003B1 (ko) * 2003-03-20 2012-02-24 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 추진제로 하이드로-플루오로-알칸을 사용하는 계량 흡입기용 제형
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
NZ552869A (en) 2004-07-02 2010-06-25 Boehringer Ingelheim Int Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CN101909652A (zh) * 2007-11-07 2010-12-08 阿斯利康(瑞典)有限公司 含有抗坏血酸衍生物的干粉制剂
WO2012032010A1 (en) * 2010-09-06 2012-03-15 Chiesi Farmaceutici S.P.A. Metered-dose inhaler and method of using the same
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
GEP20217240B (en) * 2016-09-19 2021-03-25 Mexichem Fluor Sa De Cv Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259383B1 (de) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Pharmazeutikum sowie verfahren zu seiner herstellung
EP0240484B1 (de) † 1986-03-10 1992-01-15 Kurt Dr. Burghart Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
WO1992006675A1 (en) † 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE339952T1 (de) † 1991-06-10 2006-10-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE69208660T2 (de) † 1991-06-10 1996-07-11 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
ES2099415T3 (es) * 1991-12-18 1997-05-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (en) † 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
ES2244008T3 (es) † 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
ATE219355T1 (de) † 1997-02-05 2002-07-15 Jago Res Ag Medizinische aerosolformulierungen

Also Published As

Publication number Publication date
EP0920302A1 (en) 1999-06-09
SI0920302T2 (sl) 2006-10-31
DE69807420T3 (de) 2006-11-16
EE03664B1 (et) 2002-04-15
NZ334149A (en) 2000-07-28
SK284430B6 (sk) 2005-04-01
IT1293803B1 (it) 1999-03-10
IS2435B (is) 2008-10-15
RS51274B (sr) 2010-12-31
UA70289C2 (uk) 2004-10-15
HRP980317A2 (en) 1999-04-30
TNSN98087A1 (fr) 2005-03-15
AU8626298A (en) 1998-12-30
EP0920302B1 (en) 2002-08-28
MEP44008A (en) 2011-02-10
EA199900201A1 (ru) 1999-06-24
SI0920302T1 (en) 2002-12-31
CA2263445C (en) 2008-09-09
HK1022271A1 (en) 2000-08-04
BG103221A (en) 1999-09-30
MY119074A (en) 2005-03-31
WO1998056349A1 (en) 1998-12-17
ITMI971798A1 (it) 1999-01-28
PL331531A1 (en) 1999-07-19
DE69807420T2 (de) 2003-05-08
DE69807420D1 (de) 2002-10-02
BR9805993B1 (pt) 2009-05-05
JP2000516965A (ja) 2000-12-19
MA26507A1 (fr) 2004-12-20
ZA985136B (en) 1999-01-07
EP0920302B2 (en) 2006-06-21
ES2182351T3 (es) 2003-03-01
IL128484A0 (en) 2000-01-31
CZ46299A3 (cs) 1999-07-14
HUP0001339A3 (en) 2000-10-30
PL193721B1 (pl) 2007-03-30
EA001259B1 (ru) 2000-12-25
KR100546239B1 (ko) 2006-01-26
CA2263445A1 (en) 1998-12-17
DZ2516A1 (fr) 2004-11-08
SK17699A3 (en) 1999-07-12
EP1219293A3 (en) 2003-05-28
EP1219293A2 (en) 2002-07-03
DK0920302T3 (da) 2002-12-23
PT920302E (pt) 2002-11-29
AU729966B2 (en) 2001-02-15
HUP0001339A2 (hu) 2000-09-28
CN1138532C (zh) 2004-02-18
SA98190821B1 (ar) 2006-11-19
GEP20012462B (en) 2001-06-25
GB2326334A (en) 1998-12-23
NO990594D0 (no) 1999-02-09
ES2182351T5 (es) 2007-03-16
KR20000068171A (ko) 2000-11-25
EE9900055A (et) 1999-08-16
HRP980317B1 (en) 2002-06-30
NO327775B1 (no) 2009-09-21
BR9805993A (pt) 1999-08-31
ID21491A (id) 1999-06-17
BG63906B1 (bg) 2003-06-30
HU228487B1 (en) 2013-03-28
IL128484A (en) 2004-09-27
TR199900288T1 (xx) 1999-09-21
ME00333B (me) 2011-02-10
CZ295521B6 (cs) 2005-08-17
AR012977A1 (es) 2000-11-22
DK0920302T4 (da) 2006-10-09
ATE222751T1 (de) 2002-09-15
IN189317B (es) 2003-02-08
GB9712434D0 (en) 1997-08-13
CN1229355A (zh) 1999-09-22
JP4380802B2 (ja) 2009-12-09
NO990594L (no) 1999-04-13
IS4974A (is) 1999-02-11
YU6999A (sh) 2000-03-21
TW555570B (en) 2003-10-01

Similar Documents

Publication Publication Date Title
CO4940408A1 (es) Composicion de aerosol farmaceutico
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
AR029523A1 (es) Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
PT731688E (pt) Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
AR018410A1 (es) Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron
DK0616525T3 (da) Medikamenter
CO5611092A2 (es) Formulacion superfina de formoterol
NO20012517L (no) Farmasöytisk aerosolsammensetning inneholdende HFA 227 og HFA
HUP0402487A2 (hu) Dózist adagoló inhaláló készülék
TNSN04148A1 (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
NO990454D0 (no) Aerosol-materiale
BR0107730A (pt) Inalador aerosol
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
DE60318182D1 (de) Aerosol-formulierungen mit estern von 3,17-dihydroxyöstratrien-derivaten zur pulmonalen abgabe